Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis

Clinical and Experimental Immunology

Volumn 107, Issue 2, 1997, Pages 347-352

  Ebersole, J L ^a   Machen, R L ^a   Steffen, M J ^a   Willmann, D E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

acute phase reactants; C reactive protein; haptoglobin; NSAIDs; periodontitis

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; FLURBIPROFEN; HAPTOGLOBIN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PERIODONTITIS; PRIORITY JOURNAL;

EID: 0031014624     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.270-ce1162.x     Document Type: Article

References (57)

1. Page RC, Schroeder HE. Pathogenesis of chronic inflammatory periodontal disease. A summary of current work. Lab Invest 1971; 33:235-49.
2. Page RC, The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 1991; 26:230-42.
3. Lamster IB, Novak MJ. Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. Crit Rev Oral Biol Med 1992; 3:31-60.
4. Ebersole JL, Cappelli D. Gingival crevicular fluid antibody to A. actinomycetemcomitans in periodontal disease. Oral Microbiol Immunol 1995; 9:335-44.
5. Kinane DF, Mooney J, MacFarlane TW, McDonald M, Local and systemic antibody response to putative periodontopathogens in patients with chronic periodontitis: correlation with clinical indices. Oral Microbiol Immunol 1993; 8:65-68.
6. Tew JG, Marshall DR, Burmeister JA, Ranney RR, Relationship between gingival crevicular fluid and serum antibody titers in young adults with generalized and localized periodontitis. Infect Immun 1985; 49:487-93.
7. Ebersole JL. Systemic humoral immune responses in periodontal disease. Crit Rev Oral Biol Med 1990; 1:283-331.
8. McArthur WP, Clark WB. Specific antibodies and their potential role in periodontal diseases. J Periodontol 1993; 64:807-18.
9. Trautwein C, Boker K, Manns MP. Hepatocyte and immune system: acute phase reaction as a contribution to early defense mechanisms. Gut 1994;35:1163-6.
10. Glibetic MD, Baumann H. The effect of chronic inflammation on the expression of murine acute phase plasma proteins. In: Peeters H, ed. Protides of the biological fluids. New York: Pergamon Press, 1986:513-6.
11. Steel DM. Whitehead AS. The major acule phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15:81-88.
12. Raynes JG. The acute phase response. Biochem Soc Trans 1994; 22:69-74.
13. Janssen S, Limburg PC, Buzet J, De Jong HJ, Marrink J, van Leeuwen MA. van Rijswijk MH. SAA vs. CRP in chronic inflammatory diseases. In: Peeters H, ed. Protides of the biological fluids. New York: Pergamon Press, 1986:347-50.
14. Kushner I. C-reactive protein in rheumatology. Arthritis Rheum 1991: 34:1065-8.
15. van Leeuwen MA, van Rijswijk MH, Marrink J, Westra J, de Jong HJ. CRP measurements in rheumatic disorders. In: Peeters H. ed. Protides of the biological fluids. New York: Pergamon Press. 1986:315-8.
16. Bowman BH, Adraian GS, Lum JB, Naberhaus KH. Yang F. Conserved sequences in the 5′ regions of the human transferrin (TF) and haptoglobin (Hp) genes that may relate to the acute phase reaction. In: Peeters H, ed. Protides of the biological fluids. New York: Pergamon Press, 1986:223-6.
17. van Leeuwen MA, van Rijswijk MH, van der Heijde DMFM, te Meerman GJ, van Riel PLCM, Houtman PM. van de Putte LBA, Limburg PC. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 1993: 32:9-13.
18. Kushner I. Regulation of the acute phase response by cytokines. Perspect Biol Med 1993; 36:611-22.
19. Baumann H, Gauldie J, The acute phase response. Immunol Today 1994; 15:74-80.
20. Fujihashi K, McGhee JR, Yamamoto M, Beagley KW, Kiyono H. Cytokine networks and immunoglobulin synthesis in inflamed gingival tissues. In: Genco R, ed. Molecular pathogenesis of periodontal disease. Washington, DC: American Society for Microbiology. 1994:135-45.
21. Kjeldsen M, Holmstrup P, Bendtzen K. Marginal periodontitis and cytokines: a review of the literature. J Periodontol 1993; 64:1013-22.
22. Kinane DF, Adonogianaki E, Moughal N, Winstanley FP, Mooney J. Thornhill M. Immunocytochemical characterization of cellular infiltrate, related endothelial changes and determination of GCF acute-phase proteins during human experimental gingivitis. J Periodont Res 1991; 26:286-8.
23. Sihraa PD, Reinhardt RA, Dyer JK, DuBois LM. Acute-phase protein detection and quantification in gingival crevicular fluid by direct and indirect immunodot. J Clin Periodontol 1991; 18:101-6.
24. Adonogianaki E, Moughal NA, Mooney J, Stirruups DR, Kinane DF. Acute-phase proteins in gingival crevicular fluid during experimentally induced gingivitis. J Perio Res 1994; 29:196-202.
25. Mathys EC. Host factors and generalized early onset periodontitis. Thesis. University of Texas Health Science Center at San Antonio, 1993.
26. Ebersole JL, Cappelli D, Sandoval M-N. Steffen MJ. Antigen specificity of serum antibody in A. actinomycetemcomitans infected periodontitis patients. J Dent Res 1995; 74:658-66.
27. Ebersole JL, Taubman MA, Smith DJ, Frey DE, Haffajee AD, Socransky SS. Human serum antibody responses to oral microorganisms IV. Correlation with homologous infection. Oral Microbiol Immunol 1987; 2:53-59.
28. Thompson D, Milford-Ward A, Whicher JT. The value of acute phase protein measurements in clinical practice. Ann Clin Biochem 1992; 29:123-31.
29. Ebersole JL, Singer RE, Steffensen B, Filloon T, Kornman KS. Inflammatory mediators and immunoglobulins in GCF from healthy, gingivitis, and periodontitis sites. J Perio Res 1993; 28:543-6.
30. Tonetti MS, Freiburghaus K, Lang NP, Bickel M, Detection of interleukin-8 and matrix metalloproteinases transcripts in healthy and diseased gingival biopsies by RNA/PCR. J Periodont Res 1993; 28:511-3.
31. Bickel M. The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 1993; 64:456-60.
32. Ranney RR. Immunologic mechanisms of pathogenesis in periodontal diseases: an assessment. J Periodont Res 1991; 26:243-54.
33. Chambers RE, Whicher JT. Use of serum amyloid A (SAA) protein measurements in assessing inflammatory disease. In: Peelers H, ed. Protides of the biological fluids. New York: Pergamon Press, 1986:351-4.
34. Clark GH, Fraser CG. Biological variation of acute phase proteins. Ann Clin Biochem 1993; 30:373-6.
35. Bienvenu J, Bienvenu F, Sann L. Acute phase proteins in the neonate: normal values and clinical interest in disease. In: Peeters H, ed Protides of the biological fluids. New York: Pergamon Press, 1986:573-9.
36. Fourcyrous M, Bada HS, Korones SB, Barrett FF, Jennings W, Acute phase reactants in neonatal bacterial infection. J Perinatol 1991; 11:319-25.
37. Laurent P, Mariehy J, Buffet G, Gros P, Beal B, Burn patients as typical model of acute phase response: I: Usefulness of acute phase protein changes in the blood to detect and monitor sepsis. In: Peeters H, ed. Protides of the biological fluids. New York: Pergamon Press, 1986:561-5.
38. Dofferhoff AS. Bom VJ, de Vries-Hospers HG, van Ingen J, van der Meer J, Hazenberg BP, Mulder PO, Weits J. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992; 20:185-92.
39. Gillespie SH, Dow C, Raynes JG, Behrens RH, Chiodini PL. Measurement of acute phase proteins for assessing severity of Plasmodium falciparum malaria. J Clin Pathol 1991; 44:228-31.
40. Loose LD, Sipe JD, Kirby DS et al. Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug. Br J Rheumatol 1993; 32:19-25.
41. Nagy K, Kassay L, Velkey L. Measurement of the inflammatory activity by the help of serum acute-phase proteins in juvenile chronic arthritis. Acta Univ Carol Med 1991: 37:41-45.
42. Biemond I, Verspaget HW, Wetterman IT. Acute-phase reactants and activity of Crohn's disease. In: Peeters H, ed. Protides of the biological fluids. New York: Pergamon Press, 1986:617-20.
43. Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodont Res 1993; 28:478-86.
44. Gregory RL. Dental caries vaccines: science and status. Compendium 1994; 15:1282-6.
45. Hollister MC, Weintraub JA. The association of oral status with systemic health, quality of life, and economic productivity. J Dent Educ 1993; 57:901-12.
46. Scully C, Porter SR, Mutlu S. Changing, subject-based risk factors for destructive periodontitis. In: Johnson NW, ed. Periodontal diseases: markers of disease susceptibility and activity. Cambridge: Cambridge University Press, 1991:139-78.
47. Page RC, Altman LC, Ebersole JL. Vandesteen GE, Dahlberg WH. Williams BL, Osterberg SK. Rapidly progressive periodontitis. A distinct clinical condition. J Periodontol 1983; 54:197-209.
48. Genco RJ, Zambon JJ. Christersson LA. The role of specific bacteria in periodontal disease: the origin of periodontal infections. Adv Dent Res 1988; 2:245-59.
49. Page RC. Severe forms of periodontitis in children, juveniles and adults: worldwide prevalence. In: Johnson NW, ed. Periodontal diseases: markers of disease susceptibility and activity. Cambridge: Cambridge University Press. 1991:76-106.
50. Socransky SS, Haffajee AD. Evidence of bacterial etiology: a historical perspective. Periodontology 2000 1994; 5:7-25.
51. Haffajee AD, Socransky SS, Microbial etiological agents of destructive periodontal diseases. Periodontology 2000 1994; 5:78-111.
52. Hernichel-Gorbach E, Kornman KS, Holt SC, Nichols F, Meador H, Kung JT, Thomas CA. Host responses in patients with generalized refractory periodontitis. J Periodontol 1994: 65:8-16.
53. Johnson NW, Griffiths GS, Wilton JM, Maiden MF, Curtis MA, Gillett IR, Wilson DT, Sterne JA. Detection of high-risk groups and individuals for periodontal diseases. Evidence for the existence of high-risk groups and individuals and approaches to their detection. J Clin Periodontol 1988; 15:276-82.
54. Williams RC, Jeffcoat MK, Kaplan JL, Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science 1985: 227:640-2.
55. Jeffcoat MK, Reddy MS, Haigh S et al. A comparison of topical ketoprolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 1995; 66:329-38.
56. Menkes CJ. Effects of disease-modifying anti-rheumatic drugs, steroids and non-steroidal anti-inflammatory drugs on acute-phase proteins in rheumatoid arthritis. Br J Rheumatol 1993; 32:14-18.
57. Cush JJ, Lipsky PE, Posthlethwaite AE. Schrohenloher RE. Saway A, Koopman WJ. Correlation of serologic indicators of inflammation with effectiveness of non-steroidal anti-inflammatory drug therapy in rheumatoid arthritis. Arthritis Rheum 1990; 33:19-28.